Skip to main content

Tumor Suppressor Genes

  • Chapter

Abstract

This is an oversimplification of the myriad of molecular functions under the control of these genes. Proto-oncogenes,as we discussed in the last chapter, encode for proteins in the cell signaling pathway and apoptosis. When mutated into oncogenes, their function results in an unregulated stimulation of cell division. Mutated oncogenes act in a dominant genetic mode, producing an abnormal phenotype, even though a second allele of the gene is not mutated. Tumor suppressor genes (at one time called antioncogenes) have the normal physiologic role of retarding cell division. Tumor suppressor genes differ from oncogenes in several other ways besides their opposing effects on cell division. Tumor suppressor genes do not exist in a viral form, as is the case for oncogenes. This should not be surprising. A retrovirus benefits from carrying an oncogene along in its genome to promote division in cells it infects. There would be no benefit to a virus in carrying a copy of a tumor suppressor gene to retard cell division. Tumor suppressor genes work with the DNA repair system, so necessary in maintaining the stability of the genome. Tumor suppressor genes in mutated form can be passed on as germline heritable DNA defects. They are the cause of the syndromes of genetic predisposition to cancer. However, tumor suppressor gene mutations occur more commonly as sporadic somatic cell mutations in nonfamilial cancers. Tumor suppressor genes are recessive. Both copies of the gene must be mutated to produce the phenotype: failure to inhibit growth of damaged cells. Table 4.1 lists these contrasting features of oncogenes and tumor suppressor genes.

Article Footnote

“Oncogenes promote cell growth; tumor suppressor genes inhibit it.”

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Begley S. The cancer killer. Newsweek, Dec 23, 1996: 42–47.

    Google Scholar 

  • Fearon ER. Human cancer syndromes: clues to the origin and nature of cancer. Science. 1997;278:1043–1050.

    Article  PubMed  CAS  Google Scholar 

  • Fearon ER, Vogelstein B. Tumor suppressor and DNA repair gene defects in human cancer. In: Holland JF, Bast RC, Morton DL, Frei E, Kufe DW, Weichselbaum RR, eds. Cancer Medicine. 4th ed. Baltimore: Williams and Wilkins; 1997:97–117.

    Google Scholar 

  • Tumor Protein p53; TP53. http://www.ncbi.nlm.nih.gov/cgi-bin/SCIENCE96/gene?TP53.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer Science+Business Media New York

About this chapter

Cite this chapter

Ross, D.W. (1998). Tumor Suppressor Genes. In: Introduction to Oncogenes and Molecular Cancer Medicine. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-1662-9_4

Download citation

  • DOI: https://doi.org/10.1007/978-1-4612-1662-9_4

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-98392-9

  • Online ISBN: 978-1-4612-1662-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics